Sentinel lymph node mapping in colorectal cancer

British Journal of Surgery

Volumn 90, Issue 6, 2003, Pages 659-667

  Mulsow, J ^a   Winter, D C ^a   O'Keane, J C ^a   O'Connell, P R ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER STAGING; CANCER THERAPY; CLINICAL TRIAL; COLON CARCINOMA; DIAGNOSTIC PROCEDURE; DISEASE MARKER; ELECTRONICS; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; LAPAROSCOPY; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECTUM CARCINOMA; REVIEW; SENTINEL LYMPH NODE MAPPING; TISSUE SECTION; COLORECTAL TUMOR; METHODOLOGY; PATHOLOGY; PEROPERATIVE CARE; SENTINEL LYMPH NODE BIOPSY;

COLORECTAL NEOPLASMS; HUMANS; INTRAOPERATIVE CARE; LAPAROSCOPY; LYMPHATIC METASTASIS; SENTINEL LYMPH NODE BIOPSY;

EID: 0037900584     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4217     Document Type: Review

References (67)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29.
2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-841.
3. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) investigators. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J Clin Oncol 1999; 17: 1356-1363.
4. Cohen AM, Kelsen D, Saltz L, Minsky BD, Nelson H, Farouk R et al. Adjuvant therapy for colorectal cancer. Curr Probl Surg 1997; 34: 601-676.
5. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 2002; 26: 179-189.
6. Cianchi F, Palomba A, Boddi V, Messerini L, Pucciani F, Perigli G et al. Lymph node recovery, from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 2002; 26: 384-389.
7. Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996; 106: 209-216.
8. Hernanz F, Revuelta S, Redondo C, Madrazo C, Castillo J, Gomez-Fleitas M. Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum 1994; 37: 373-376.
9. Mainprize KS, Kulacoglu H, Hewavisinthe J, Savage A, Mortensen N, Warren BF. How many lymph nodes to stage colorectal carcinoma? J Clin Pathol 1998; 51: 165-166.
10. Cawthorn SJ, Gibbs NM, Marks CG. Clearance techniques for the detection of lymph nodes in colorectal cancer. Br J Surg 1986; 73: 58-60.
11. Scott KWM, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 1989; 76: 1165-1167.
12. Treseler PA, Tauchi PS. Pathologic analysis of the sentinel lymph node. Surg Clin North Am 2000; 80: 1695-1719.
13. Kell MR, Winter DC, O'Sullivan GC, Shanahan F, Redmond HP. The biological behaviour and clinical implications of micrometastases. Br J Surg 2000; 87: 1629-1639.
14. Braithwaite LR. The flow of lymph from the ileocaecal angle, and its possible bearing on the cause of duodenal and gastric ulcer. Br J Surg 1923; 11: 7-26.
15. Gray JH. The relation of lymphatic vessels to the spread of cancer. Br J Surg 1938; 26: 462-495.
16. Weinberg J, Greaney EM. Identification of regional lymph nodes by means of a vital staining dye during surgery of gastric cancer. Surg Gynecol Obstet 1950; 90: 561-567.
17. Halsell JT, Smith JR, Bentlage CR, Oaldey KP, Humphries JW Jr Lymphatic drainage of the breast demonstrated by vital dye staining and radiography. Ann Surg 1965; 162: 221-226.
18. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456-466.
19. Bethune DCG, Chiu RCJ, Mulder DS, Rosenthal L. In vivo mapping of pulmonary lymphatic pathways: a new technique. J Surg Res 1979; 26: 513-518.
20. Wong JH, Cagle LA, Morton DL. Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 1991; 214: 637-641.
21. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
22. Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223: 217-224.
23. Karakousis CP, Velez AF, Spellman JE Jr, Scarozza J. The technique of sentinel node biopsy. Eur J Surg Oncol 1996; 22: 271-275.
24. Kapteijn BA, Nieweg OE, Liem I, Mooi WJ, Balm AJ, Muller SH et al. Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol 1997; 4: 156-160.
25. Leong SP, Steinmetz I, Habib FA, McMillan A, Gans JZ, Allen RE Jr et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997; 132: 666-672.
26. Pijpers R, Borgstein PJ, Meijer S, Hoekstra OS, van Hattum LH, Teule GJ. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 1997; 21: 788-792.
27. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818-1822.
28. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-1867.
29. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-283.
30. Giuliano AE, Jones RC, Brennan M, Staunan R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345-2350.
31. Decesare SL, Fiorica JV, Roberts WS, Reintgen D, Arango H, Hoffman MS et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol 1997; 66: 425-428.
32. Levenback C, Burke TW, Morris M, Malpica A, Lucas KR, Gershenson DM. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 1995; 59: 216-220.
33. Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 1996; 62: 169-173.
34. Stadelmann WK, Javaheri S, Cruse CW, Reintgen DS. The use of selective lymphadenectomy in squamous cell carcinoma of the wrist: a case report. J Hand Surg [Am] 1997; 22: 726-731.
35. Wood TF, Tsioulias GJ, Morton DL, Rangel D, Hutchinson W Jr, Forshag LJ et al. Focused examination of sentinel lymph nodes upstages early colorectal carcinoma. Am Surg 2000; 66: 998-1003.
36. Saha S, Bilchik A, Wiese D, Espinosa M, Badin J, Ganatra BK et al. Ultrastaging of colorectal cancer by sentinel node mapping - a multicenter trial. Am Surg Oncol 2001; 8(Suppl): 94S-98S.
37. Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 2001; 19: 1128-1136.
38. Wiese DA, Saha S, Badin J, Ng PS, Gauthier J, Ahsan A et al. Pathologic evaluation of sentinel lymph nodes in colorectal carcinoma. Arch Pathol Lab Med 2000; 124: 1759-1763.
39. Saha S, Wiese D, Badin J, Beutler T, Nora D, Ganatra BK et al. Technical details of sentinel node lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol 2000; 7: 120-124.
40. Merrie AE, van Rij AM, Phillips LV, Rossaak JI, Yun K, McCall JL. Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum 2001; 44: 410-417.
41. Wong JH, Steineman S, Calderia C, Bowles J, Namiki T. Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg 2001; 233: 515-521.
42. Cserni G, Vajda K, Tarjan M, Bori R, Svebis M, Baltas B. Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathol Oncol Res 1999; 5: 291-296.
43. Joosten JJA, Strobbe LJA, Wauters CAP, Pruszczynski M, Wobbes Th, Ruers TJM. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999; 86: 482-486.
44. Waters GS, Geisinger KR, Garske DD, Loggie BW, Levine EA. Sentinel lymph node mapping for carcinoma of the colon: a pilot study. Am Surg 2000; 66: 943-945.
45. Paramo JC, Summerall J, Wilson C, Cabral A, Willis I, Wodnicki H et al. Intraoperative sentinel lymph node mapping in patients with colon cancer. Am J Surg 2001; 182: 40-43.
46. Esser S, Reilly WT, Riley LB, Eyvazzadeh C, Arcona S. The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum 2001; 44: 850-854.
47. Feig BW, Curley S, Lucci A, Hunt KK, Vauthey JN, Mansfield PF et al. A caution regarding lymphatic mapping in patents with colon cancer. Am J Surg 2001; 182: 707-712.
48. Bendavid Y, Latulippe JF, Younan RJ, Leclerc YE, Dube S, Heyen F et al. Phase I study on sentinel lymph node mapping in colon cancer: a preliminary report. J Surg Oncol 2002; 79: 81-84.
49. Gandy CP, Biddlestone LR, Roe AM, O'Leary DP. Intra-operative injection of Patent Blue V dye to facilitate nodal staging in colorectal cancer. Colorectal Dis 2002; 4: 447-449.
50. Wood TF, Spirt M, Rangel D, Shen P, Tsioulias GJ, Morton DL et al. Lymphatic mapping improves staging during laparoscopic colectomy for cancer. Surg Endosc 2001; 15: 715-719.
51. Merrie AE, Phillips LV, Yun K, McCall JL. Skip metastases in colon cancer: assessment by lymph node mapping using molecular detection. Surgery 2001; 129: 684-691.
52. Davidson BR, Sams VR, Styles J, Deane C, Boulos PB. Detection of occult nodal metastases in patients with colorectal carcinoma. Cancer 1990; 65: 967-970.
53. Jeffers MD, O'Dowd GM, Mulcahy H, Stagg M, O'Donoghue DP, Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994; 172: 183-187.
54. Oberg A, Stenling R, Tavelin B, Lindmark G. Are lymph node micrometastases of any clinical significance in Dukes' stages A and B colorectal cancer? Dis Colon Rectum 1998; 41: 1244-1249.
55. Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg 1996; 162: 637-642.
56. Broll R, Schauer V, Schimmelpenning H, Strik M, Woltmann A, Best R et al. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immuno-histochemical study. Dis Colon Rectum 1997; 40: 1465-1471.
57. Cutait R, Alres VAF, Lopes LC, Cutait DE, Borges JLA, Singer J et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991; 34: 917-922.
58. Choi HJ, Choi YY, Hong SH. Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes' B colorectal carcinoma. Dis Colon Rectum 2002; 45: 750-755.
59. Clarke G, Ryan E, O'Keane JC, Crowe J, MacMathuna P. The detection of cytokeratins in lymph nodes of Dukes' B colorectal cancer subjects predicts a poor outcome. Eur J Gastroenterol Hepatol 2000; 12: 549-552.
60. Greenson JK, Isenhart GE, Rice R, Mojzisik C, Houchens D, Martin EW Jr Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994; 73: 563-569.
61. Haboubi NY, Abdalla SA, Amini S, Clarke P, Dougal M, Dube A et al. The novel combination of fat clearance and immunohistochemistry improves prediction of the outcome of patients with colorectal carcinomas: a preliminary study. Int J Colorectal Dis 1998; 13: 99-102.
62. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998; 339: 223-228.
63. Rosenberg R, Hoos A, Mueller J, Baier P, Stricker D, Werner M et al. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 2002; 20: 1049-1055.
64. Clarke GA, Ryan E, Crowe JP, O'Keane JC, MacMathuna P. Tumour derived mutated K-ras codon 12 expression in regional lymph nodes of stage II colorectal cancer patients is not associated with increased risk of cancer-related death. Int J Colorectal Dis 2001; 16: 108-111.
65. Thebo JS, Senagore AJ, Reinhold DS, Stapleton SR. Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes' B patients. Dis Colon Rectum 2000; 43: 155-159.
66. Hayashi N, Ito I, Yanagisawa A, Kato Y, Nakamori S, Imaoka S et al. Genetic diagnosis of lymph-node metastases in colorectal cancer. Lancet 1995; 345: 1257-1259.
67. Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Hirabayashi Y, Kitano S. Pattern of lymph node micrometastases and prognosis of patients with colorectal cancer. Ann Surg Oncol 2001; 8: 300-304.